Can You Hear Me Now? Engaging Patients in Virtual Shared Decision-Making

This activity is part of a series


Mintu P. Turakhia, MD, MAS
Associate Professor
Executive Director, Center for Digital Health, Stanford University School of Medicine
Director of Cardiac Electrophysiology, VA Palo Alto Health Care System, Palo Alto, CA
Mintu P. Turakhia, MD, MAS

Mintu Turakhia, MD, MAS, is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. He is the Director of the Stanford Center for Digital Health (CDH) and the newly-formed American Heart Association-funded Heart Health Technology Center. In his clinical role, he performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders.

Dr. Turakhia has an active multidisciplinary program in heart rhythm and digital health research, where he uses biostatistical, health economic, artificial intelligence, and data science approaches to examine quality, outcomes, and risk of heart rhythm disorders such as atrial fibrillation in very large datasets. He is a principal investigator of several multi-center trials, such as the Apple Heart Study, to test digital health tools and wearables, and he collaborates closely on research with medical device and technology companies. Dr. Turakhia has published over 200 manuscripts and is an elected member of the American Society for Clinical Investigation, and a Fellow of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Turakhia has served as an advisor and investor to over 25 medical device, drug, and health technology companies across their life cycle, from early stage to IPO.

Geoffrey Barnes, MD, MSc
Assistant Professor, Cardiovascular Medicine and Vascular Medicine
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, MI
Geoffrey Barnes, MD, MSc
Assistant Professor, Cardiovascular Medicine and Vascular Medicine

Dr. Barnes is a cardiologist and vascular medicine specialist at the University of Michigan Health System. His clinical and research interests center around the care of patients with thrombotic conditions and/or who require the use of anticoagulant medications. He is also a health services researcher with expertise in implementation science. He serves as co-director for the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) and is currently funded by NHLBI and AHRQ to improve the delivery of anticoagulation care. He serves in leadership roles with numerous organizations, including the Anticoagulation Forum, American College of Cardiology, and American Heart Association.

Associate Professor, Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University, Philadelphia, PA

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL is Associate Professor for the Department of Family & Community Medicine at the Lewis Katz School of Medicine at Temple University and Temple University Hospital, and Chief Quality Officer for the Temple Faculty Practice Plan. She is an attending physician at Temple University Hospital (Philadelphia, PA) and Christiana Care Health System (Wilmington, DE). Dr. Savoy graduated from the University of Maryland School of Medicine in 2002, completed Family Medicine Residency Program at the Crozer-Keystone Family Medicine Residency Program (Springfield, PA) in 2005, and graduated from the University of North Carolina Chapel Hill Gillings School of Global Public Health in 2008 with a Master’s degree in Public Health in Public Health Leadership with a focus on Public Health Practice. She is certified by the American Board of Family Medicine, the Certifying Commission in Medical Management, and is a Fellow of the Advisory Board Company.

Statement of Need

Fewer than half of high-risk patients with atrial fibrillation (AF) receive recommended anticoagulation therapy for stroke prevention, and of those who start anticoagulation, 30% – 50% stop treatment within 12 months. Shared decision-making (SDM) can improve adherence to anticoagulant therapy and should be used to individualize anticoagulant therapy based on each patient’s risk of stroke and bleeding and personal preferences.

The final installment of this CME Outfitters BriefCase series focuses on patient education and SDM when providing care via telemedicine, including use of digital decision aids and electronic resources to assist with SDM, developing individualized treatment plans, overcoming social health care disparities, building trust with patients in a virtual care setting, and reinforcing the importance of adherence and persistence to prescribed therapy.

Learning Objectives

At the end of this CME/CE activity, participants should be able to utilize digital decision aids for patient education and SDM when providing care via telemedicine.

The following learning objectives pertain only to those requesting CNE or CPE credit: Explain digital decision aids for patient education and SDM for care via telemedicine.

Financial Support

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Target Audience

Primary care physicians, cardiologists, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Turakhia reports that he receives grants from the American Heart Association; Apple Inc.; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; Cardiva Medical, Inc.; Janssen Pharmaceuticals, Inc.; and SentreHEART, Inc. He is a consultant for Abbott; BIOTRONIK, Inc.; Cardiva Medical, Inc.; iRhythm Technologies, Inc.; Johnson & Johnson; Medtronic; Milestone Pharmaceuticals, Inc.; MyoKardia, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi. He receives other financial or material support as an editor for JAMA Cardiology.

Dr. Tarakji reports that he is a consultant for AliveCor, Inc.; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; and Medtronic.

Dr. Savoy has no disclosures to report.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-112-H01-P


Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.




Can You Hear Me Now? Engaging Patients in Virtual Shared Decision-Making
Event Date: 04/26/2021